Literature DB >> 30599296

A case of recurrent MOG antibody positive bilateral optic neuritis and anti-NMDAR encephalitis: Different biological evolution of the two associated antibodies.

Bojan Rojc1, Barbara Podnar2, Francesc Graus3.   

Abstract

We report the clinical association of myelin-oligodendrocyte-glycoprotein (MOG) IgG-associated encephalomyelitis (MOG-EM) and anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis. A 47-year old male presented to our hospital with right eye optic neuritis in February 2018. He had a history of recurrent bilateral optic neuritis since 2001 and in 2013 was treated of a anti-NMDAR encephalitis. He never had any CNS demyelination event besides optic neuritis. At the time of anti-NMDAR encephalitis both NMDAR and MOG antibodies were positive in serum and CSF. At the last visit, serum aquaporin-4 (AQP-4) and NMDAR antibodies were negative but MOG antibodies remained positive. MOG-EM and NMDAR encephalitis can present over an extended period of time without other signs of CNS demyelination and with a different temporal evolution of the associated antibodies.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anti-N-methyl-d-aspartate receptor encephalitis; Myelin-oligodendrocyte-glycoprotein antibody; N-methyl-d-aspartate receptor antibody; Optic neuritis

Mesh:

Substances:

Year:  2018        PMID: 30599296     DOI: 10.1016/j.jneuroim.2018.12.003

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  5 in total

Review 1.  Clinical Characteristics of Anti-N-Methyl-d-Aspartate Receptor Encephalitis Overlapping with Demyelinating Diseases: A Review.

Authors:  Shujiang Zhang; Yuan Yang; Wenyu Liu; Zuoxiao Li; Jinmei Li; Dong Zhou
Journal:  Front Immunol       Date:  2022-06-28       Impact factor: 8.786

2.  MOG-IgG1 and co-existence of neuronal autoantibodies.

Authors:  Amy Kunchok; Eoin P Flanagan; Karl N Krecke; John J Chen; J Alfredo Caceres; Justin Dominick; Ian Ferguson; Revere Kinkel; John C Probasco; Miguel Ruvalcaba; Jonathan D Santoro; Kurt Sieloff; Jeremy Timothy; Brian G Weinshenker; Andrew McKeon; Sean J Pittock
Journal:  Mult Scler       Date:  2020-09-10       Impact factor: 6.312

Review 3.  Clinical features and management of coexisting anti-N-methyl-D-aspartate receptor encephalitis and myelin oligodendrocyte glycoprotein antibody-associated encephalomyelitis: a case report and review of the literature.

Authors:  Di Nan; Ying Zhang; Jinming Han; Tao Jin
Journal:  Neurol Sci       Date:  2021-01-07       Impact factor: 3.307

4.  Overlapping syndrome of recurrent anti-N-methyl-D-aspartate receptor encephalitis and anti-myelin oligodendrocyte glycoprotein demyelinating diseases: A case report.

Authors:  Xue-Jing Yin; Li-Fang Zhang; Li-Hua Bao; Zhi-Chao Feng; Jin-Hua Chen; Bing-Xia Li; Juan Zhang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 5.  Coexistence of Myelin Oligodendrocyte Glycoprotein Immunoglobulin G and Neuronal or Glial Antibodies in the Central Nervous System: A Systematic Review.

Authors:  Cong Zhao; Pei Liu; Daidi Zhao; Jiaqi Ding; Guangyun Zhang; Hongzeng Li; Jun Guo
Journal:  Brain Sci       Date:  2022-07-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.